Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis
Authors
Keywords
B16F10 melanoma, Metastasis, Coagulation, Platelet, Concomitant tumor resistance
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 94, Issue 8, Pages 899-910
Publisher
Springer Nature
Online
2016-04-06
DOI
10.1007/s00109-016-1415-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial
- (2016) Fergus Macbeth et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-molecular-weight heparins and cancer: Focus on antitumoral effect
- (2015) Massimo Franchini et al. ANNALS OF MEDICINE
- Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells
- (2015) Renan Orellana et al. BMC CANCER
- Concomitant resistance and early-breast cancer: should we change treatment strategies?
- (2013) Carlos M. Galmarini et al. CANCER AND METASTASIS REVIEWS
- Concomitant tumor resistance
- (2012) Paula Chiarella et al. CANCER LETTERS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- The Initial Hours of Metastasis: The Importance of Cooperative Host-Tumor Cell Interactions during Hematogenous Dissemination
- (2012) M. Labelle et al. Cancer Discovery
- Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain
- (2011) N. A. Horowitz et al. BLOOD
- Antithrombotic therapy and survival in patients with malignant disease
- (2010) A K Kakkar et al. BRITISH JOURNAL OF CANCER
- Antithrombotic therapy and survival in cancer patients
- (2009) A.K. Kakkar BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Procoagulant mechanisms in tumour cells
- (2009) Anna Falanga et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner
- (2009) Luize G. Lima et al. CANCER LETTERS
- Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis
- (2009) C. E. Holmes et al. CLINICAL & EXPERIMENTAL METASTASIS
- Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines
- (2009) Clarice Kirszberg et al. MELANOMA RESEARCH
- An overview of coagulation disorders in cancer patients
- (2009) Slavica Kvolik et al. SURGICAL ONCOLOGY-OXFORD
- The effects of surgery on tumor growth: a century of investigations
- (2008) R. Demicheli et al. ANNALS OF ONCOLOGY
- Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung
- (2008) Tatjana M. H. Niers et al. CLINICAL & EXPERIMENTAL METASTASIS
- Effect of anti-fibrinolytic therapy on experimental melanoma metastasis
- (2008) Jennifer M. Kirstein et al. CLINICAL & EXPERIMENTAL METASTASIS
- The role of platelet activation in tumor metastasis
- (2008) Lubor Borsig Expert Review of Anticancer Therapy
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
- (2008) J. S. PALUMBO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More